Treatment of childhood acute myeloid leukaemia

Affiliations

Review

J W Taub et al. Baillieres Clin Haematol. 1996 Mar.

. 1996 Mar;9(1):129-46.

doi: 10.1016/s0950-3536(96)80040-0.

¹ Wayne State University School of Medicine, Children's Hospital of Michigan, Detroit 48201-2196, USA.

No abstract available

Similar articles

Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: a report from the Childrens Cancer Group.
Nesbit ME Jr, Buckley JD, Feig SA, Anderson JR, Lampkin B, Bernstein ID, Kim TH, Piomelli S, Kersey JH, Coccia PF, et al. Nesbit ME Jr, et al. J Clin Oncol. 1994 Jan;12(1):127-35. doi: 10.1200/JCO.1994.12.1.127. J Clin Oncol. 1994. PMID: 8270968 Clinical Trial.
The treatment of acute leukaemia.
Burnett AK, Eden OB. Burnett AK, et al. Lancet. 1997 Jan 25;349(9047):270-5. doi: 10.1016/s0140-6736(96)08086-5. Lancet. 1997. PMID: 9014927 Review.
Treatment of acute leukemia.
Lechner K, Geissler K, Jäger U, Greinix H, Kalhs P. Lechner K, et al. Ann Oncol. 1999;10 Suppl 6:45-51. Ann Oncol. 1999. PMID: 10676552 Review.
[Principles of relapse therapy in acute myeloid leukemia].
Hiddemann W, Büchner T, van de Loo J. Hiddemann W, et al. Dtsch Med Wochenschr. 1989 Apr 14;114(15):599-605. doi: 10.1055/s-2008-1066643. Dtsch Med Wochenschr. 1989. PMID: 2649351 Review. German. No abstract available.
Successful induction of molecular remission with single-agent anti-CD33 antibody (gemtuzumab ozogamicin) in chemotherapy-refractory relapse of acute myeloid leukaemia post-BMT.
Swords R, Hayden PJ, Molloy K, Lawlor M, Browne PV, Murphy PT. Swords R, et al. Eur J Haematol. 2004 Dec;73(6):450-1. doi: 10.1111/j.1600-0609.2004.00321.x. Eur J Haematol. 2004. PMID: 15522070 No abstract available.

Factors in improved survival from paediatric cancer.
Taub JW. Taub JW. Drugs. 1998 Nov;56(5):757-65. doi: 10.2165/00003495-199856050-00002. Drugs. 1998. PMID: 9829151 Review.
Transcriptional regulation of the human cystathionine beta-synthase -1b basal promoter: synergistic transactivation by transcription factors NF-Y and Sp1/Sp3.
Ge Y, Konrad MA, Matherly LH, Taub JW. Ge Y, et al. Biochem J. 2001 Jul 1;357(Pt 1):97-105. doi: 10.1042/0264-6021:3570097. Biochem J. 2001. PMID: 11415440 Free PMC article.